It’s only fair to share… Cendifensine CAS 1034048-49-1 MF C14H17Cl2NO MW286.2 g/mol Methanone, (3,4-dichlorophenyl)[(3S)-3-propyl-3-pyrrolidinyl]- (3,4-dichlorophenyl)[(3S)-3-propylpyrrolidin-3-yl]methanonemonoamine reuptake inhibitor, NOE-115, NOE 115, N4U2JR8GCX, Cendifensine (INNTooltip International Nonproprietary Name) is a monoamine reuptake inhibitor (MRI)[1] related to the amphetamines and cathinones which has not been marketed at this time.[2][3][4] It was first described by 2013[4] and its INNTooltip International Nonproprietary Name was proposed in 2024.[2] The drug has been patented by Noema Pharma, which …